CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This research focuses on understanding the mechanisms of relapse in T cell acute lymphoblastic leukaemia. By analyzing genetic changes in leukemia cells during and after chemotherapy, the project aims to identify early-stage resistant clones and improve treatment strategies.
T cell acute lymphoblastic leukaemia (T-ALL) is a rare disease that affects around 10-13 individuals in one million and affects pediatric and adult patients.
High-dose chemotherapy is an adequate therapeutic treatment for most patients, however 10-20% of patients relapse and will require a bone marrow transplantation as a unique therapeutic window. T-ALL is a very aggressive disease and the rapidness in the response is crucial, however, one problem is that we cannot predict which patients will r…
FUNDACIO INSTITUT HOSPITAL DEL MAR D INVESTIGACIONS MEDIQUES
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
